Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 26, 2006Proceedings of the National Academy of Sciences

A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMegan WhitnallJHJonathan HowardPPPrem Ponka

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Whitnall et al. (2006) studied this question.

synapsesocial.com/papers/6a7063ce6c240de38cdbc8fchttps://doi.org/10.1073/pnas.0604979103
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Iron Chelators in Cancer Chemotherapy2004 · 202 citations
  2. 2Reduction of Ribonucleotides1979 · 1,174 citations
  3. 3The Potential of Iron Chelators of the Pyridoxal Isonicotinoyl Hydrazone Class as Effective Antiproliferative Agents II: The Mechanism of Action of Ligands Derived From Salicylaldehyde Benzoyl Hydrazone and 2-Hydroxy-1-Naphthylaldehyde Benzoyl Hydrazone1997 · 208 citations
  4. 4Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity2000 · 368 citations
  5. 5The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents1995 · 349 citations